{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:27:18Z","timestamp":1788280038041,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Preexisting CKD, elevated serum creatinine, and severe interstitial fibrosis and tubular atrophy were linked to poor renal prognosis in renal sarcoidosis.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Steroid therapy was strongly associated with renal recovery and improved long-term outcomes in renal sarcoidosis.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Early detection and management of renal involvement in sarcoidosis are critical to preventing irreversible kidney damage.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renal sarcoidosis (RS) is a rare but potentially severe manifestation of sarcoidosis, primarily affecting the kidneys through granulomatous interstitial nephritis and calcium metabolic disturbances. This study evaluates the clinicopathologic features and renal outcomes of biopsy-proven RS, focusing on identifying predictors of renal recovery and disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 43 biopsy-proven RS at Mayo Clinic (2012\u20132024). Demographic, clinical, laboratory, and histopathologic data were analyzed. Renal recovery within 6 months was classified as complete, partial, or no recovery based on serum creatinine (sCr) changes. Long-term adverse composite outcomes included the CKD onset, CKD progression, ESKD, dialysis initiation, or death. Logistic regression and Cox proportional hazards regression were used to assess predictors of renal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the cohort, 84% exhibited interstitial nephritis, with granulomatous interstitial nephritis in 33%. Calcium phosphate deposits were found in 58% of cases. Hypercalciuria (90%) was more common than hypercalcemia (74%). Within 6 months, 86% achieved recovery (74% complete, 12% partial), while 40% experienced long-term adverse composite outcomes. Higher sCr at biopsy (\u22652.4 mg\/dl) and moderate-to-severe interstitial fibrosis and tubular atrophy were associated with reduced complete recovery and worse long-term outcomes, while preexisting CKD significantly increased the risk of adverse long-term outcomes. Steroid therapy significantly increased the likelihood of complete recovery and reduced the risk of adverse long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Preexisting CKD, elevated sCr at biopsy, interstitial fibrosis and tubular atrophy, and steroid therapy are key predictors of renal outcomes in RS. Early diagnosis and intervention are crucial to preventing irreversible kidney damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000000842","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:01:15Z","timestamp":1748865675000},"page":"1780-1789","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Clinicopathological Characteristics and Long-Term Kidney Outcomes in Biopsy-Proven Renal Sarcoidosis"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-9740","authenticated-orcid":false,"given":"Jing","family":"Miao","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-3604","authenticated-orcid":false,"given":"Charat","family":"Thongprayoon","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-9711","authenticated-orcid":false,"given":"Wisit","family":"Cheungpasitporn","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6365-0859","authenticated-orcid":false,"given":"Alessia","family":"Buglioni","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9809","authenticated-orcid":false,"given":"Ladan","family":"Zand","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9952-209X","authenticated-orcid":false,"given":"Fernando","family":"Fervenza","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"B1-20251101","doi-asserted-by":"crossref","first-page":"106548","DOI":"10.1016\/j.rmed.2021.106548","article-title":"Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up","volume":"187","author":"Sikj\u00e6r","year":"2021","journal-title":"Respir Med."},{"issue":"4","key":"B2-20251101","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells."},{"key":"B3-20251101","doi-asserted-by":"crossref","first-page":"107608","DOI":"10.1016\/j.rmed.2024.107608","article-title":"Organ involvement in newly diagnosed sarcoidosis patients in The Netherlands: the first large European multicentre prospective study","volume":"226","author":"Van Woensel","year":"2024","journal-title":"Respir Med."},{"issue":"3","key":"B4-20251101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccm.2008.03.007","article-title":"Genetics of sarcoidosis","volume":"29","author":"M\u00fcller-Quernheim","year":"2008","journal-title":"Clin Chest Med."},{"key":"B5-20251101","doi-asserted-by":"crossref","first-page":"103207","DOI":"10.1016\/j.jaut.2024.103207","article-title":"Kidney manifestations of sarcoidosis","volume":"149","author":"Bonella","year":"2024","journal-title":"J Autoimmun."},{"key":"B6-20251101","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1750-1172-8-65","article-title":"Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study","volume":"8","author":"Stehl\u00e9","year":"2013","journal-title":"Orphanet J Rare Dis."},{"issue":"5","key":"B7-20251101","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MCP.0000000000000504","article-title":"Renal sarcoidosis: approach to diagnosis and management","volume":"24","author":"Bergner","year":"2018","journal-title":"Curr Opin Pulm Med."},{"issue":"2","key":"B8-20251101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2215\/CJN.01790506","article-title":"Granulomatous interstitial nephritis","volume":"2","author":"Joss","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B9-20251101","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","article-title":"Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients","volume":"88","author":"Mah\u00e9vas","year":"2009","journal-title":"Medicine (Baltimore)."},{"issue":"10","key":"B10-20251101","doi-asserted-by":"crossref","first-page":"e110778","DOI":"10.1371\/journal.pone.0110778","article-title":"Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course","volume":"9","author":"Bagnasco","year":"2014","journal-title":"PLoS One."},{"issue":"3","key":"B11-20251101","first-page":"252","article-title":"Clinical characteristics of biopsy-proven renal sarcoidosis in Japan","volume":"35","author":"Kamata","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"issue":"10","key":"B12-20251101","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000530668","article-title":"Clinicopathological characteristics and outcomes of renal sarcoidosis: a series study of 18 patients from a single center","volume":"147","author":"Zhu","year":"2023","journal-title":"Nephron."},{"key":"B14-20251101","doi-asserted-by":"crossref","first-page":"107121","DOI":"10.1016\/j.rmed.2023.107121","article-title":"Renal disease in sarcoidosis patients in a German multicentric retrospective cohort study","volume":"209","author":"Bergner","year":"2023","journal-title":"Respir Med."},{"key":"B15-20251101","doi-asserted-by":"crossref","first-page":"568020","DOI":"10.3389\/fmed.2020.568020","article-title":"Hypercalciuria in sarcoidosis: a specific biomarker with clinical utility","volume":"7","author":"Cameli","year":"2020","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"B16-20251101","first-page":"306","article-title":"Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients","volume":"31","author":"L\u00f6ffler","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"issue":"6","key":"B17-20251101","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4103\/1319-2442.275471","article-title":"Tubulointerstitial nephritis due to sarcoidosis: clinical, laboratory, and histological features and outcome in a cohort of 24 patients","volume":"30","author":"Zammouri","year":"2019","journal-title":"Saudi J Kidney Dis Transpl."},{"issue":"5","key":"B18-20251101","first-page":"721","article-title":"The protean face of renal sarcoid","volume":"16","author":"Carmichael","year":"2003","journal-title":"J Nephrol."},{"issue":"3","key":"B19-20251101","first-page":"e2021017","article-title":"Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey","volume":"38","author":"Rastelli","year":"2021","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"issue":"2","key":"B20-20251101","first-page":"167","article-title":"Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study","volume":"13","author":"Rizzato","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"issue":"10","key":"B21-20251101","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/ndt\/gft442","article-title":"Treatment of renal sarcoidosis: is there a guideline? Overview of the different treatment options","volume":"29","author":"Hilderson","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B22-20251101","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MCP.0000000000000400","article-title":"Current concepts regarding calcium metabolism and bone health in sarcoidosis","volume":"23","author":"Baughman","year":"2017","journal-title":"Curr Opin Pulm Med."},{"issue":"2","key":"B23-20251101","doi-asserted-by":"crossref","first-page":"100032","DOI":"10.1016\/j.pharmr.2024.100032","article-title":"Vitamin D and its analogs in immune system regulation","volume":"77","author":"Artusa","year":"2025","journal-title":"Pharmacol Rev."},{"issue":"6","key":"B24-20251101","doi-asserted-by":"crossref","first-page":"e0287169","DOI":"10.1371\/journal.pone.0287169","article-title":"Vitamin D status & associations with inflammation in older adults","volume":"18","author":"Laird","year":"2023","journal-title":"PLoS One."},{"issue":"12","key":"B25-20251101","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the national health and nutrition examination survey (NHANES): 2001-2006","volume":"96","author":"Skversky","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"B26-20251101","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/hr.2017.98","article-title":"Glucocorticoid exposure induces preeclampsia via dampening 1,25-dihydroxyvitamin D(3)","volume":"41","author":"Zhang","year":"2018","journal-title":"Hypertens Res."},{"issue":"8","key":"B27-20251101","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"issue":"1-2","key":"B28-20251101","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jsbmb.2010.03.081","article-title":"Glucocorticoid regulation of the vitamin D receptor","volume":"121","author":"Hidalgo","year":"2010","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"4","key":"B29-20251101","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000187864","article-title":"Membranous nephropathy and granulomatous interstitial nephritis in sarcoidosis","volume":"66","author":"Khan","year":"1994","journal-title":"Nephron."},{"issue":"11","key":"B30-20251101","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2169\/internalmedicine.38.882","article-title":"Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis","volume":"38","author":"Toda","year":"1999","journal-title":"Intern Med."},{"issue":"5","key":"B31-20251101","first-page":"340","article-title":"Acute renal failure due to IgA nephropathy in sarcoidosis","volume":"13","author":"Akbari","year":"2019","journal-title":"Iran J Kidney Dis."},{"issue":"1","key":"B32-20251101","first-page":"69","article-title":"Sarcoidosis complicated with IgA nephropathy","volume":"20","author":"Hamada","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B33-20251101","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13256-015-0764-8","article-title":"Necrotizing crescentic glomerulonephritis related to sarcoidosis: a case report","volume":"9","author":"Maroz","year":"2015","journal-title":"J Med Case Rep."},{"issue":"6","key":"B34-20251101","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ndt\/gfv080","article-title":"Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy","volume":"30","author":"Stehl\u00e9","year":"2015","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B35-20251101","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.ki.5001512","article-title":"Sarcoid tubulo-interstitial nephritis: long-term outcome and response to corticosteroid therapy","volume":"70","author":"Rajakariar","year":"2006","journal-title":"Kidney Int."},{"issue":"4","key":"B36-20251101","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/ndt\/gfac219","article-title":"Renal sarcoidosis","volume":"38","author":"Mehta","year":"2023","journal-title":"Nephrol Dial Transplant."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:17Z","timestamp":1786478357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000842","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"2025-03-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}